Seasoned medtech leader with a proven track record in scaling companiesOXFORD, UK, November 07, 2022 / B3C newswire / OxSonics Therapeutics, a clinical-stage company focused on transforming cancer treatment through SonoTran®, its ultrasound-based drug delivery platform, announces that it has appointed Jérôme.
Jérôme Marzinski Appointed as Chief Executive Officer b3cnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from b3cnewswire.com Daily Mail and Mail on Sunday newspapers.
Data from collaboration with ADC Therapeutics presented at the EORTC-NCI-AACR Symposium showed SonoTran® increased potency of ADCT-601 by 3.3 timesOXFORD, UK , October 31, 2022 / B3C newswire / OxSonics Therapeutics, a clinical-stage company focused on transforming cancer treatment through SonoTran®, its ultrasou.